IQVIA Holdings Inc.

General ticker "IQV" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $37.7B (TTM average)

IQVIA Holdings Inc. follows the US Stock Market performance with the rate: 23.4%.

Estimated limits based on current volatility of 2.0%: low 149.30$, high 155.42$

Factors to consider:

  • Company included in S&P500 list
  • North and South America accounted for 47.8% of revenue in the fiscal year ended 2024-12-31
  • Current price 13.2% below estimated low
  • Earnings for 3 months up through Q1 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [179.93$, 246.86$]
  • 2025-12-31 to 2026-12-31 estimated range: [180.55$, 249.19$]

Financial Metrics affecting the IQV estimates:

  • Positive: Non-GAAP EPS, $ of 11.14 > 2.19
  • Positive: 22.52 < Shareholder equity ratio, % of 22.55 <= 43.26
  • Positive: 2.69 < Return on assets ratio (scaled to [-100,100]) of 4.84
  • Positive: 8.37 < Operating profit margin, % of 14.29
  • Negative: Interest expense per share, $ of 3.70 > 0.67
  • Positive: Industry inventory ratio change (median), % of -0.30 <= -0.28
  • Negative: Inventory ratio change, % of 10.72 > 1.05

Similar symbols

Short-term IQV quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-12135140145150155160165170175180
Price $

Long-term IQV plot with estimates

140160180200220240260280Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 20270123
IQVS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $14,410.00MM $14,984.00MM $15,405.00MM
Operating Expenses $12,611.00MM $13,007.00MM $13,203.00MM
Operating Income $1,799.00MM $1,977.00MM $2,202.00MM
Non-Operating Income $-436.00MM $-518.00MM $-533.00MM
Interest Expense $416.00MM $672.00MM $670.00MM
Income(Loss) $1,363.00MM $1,459.00MM $1,669.00MM
Taxes $260.00MM $101.00MM $301.00MM
Other Income(Loss) $-12.00MM $0.00MM $5.00MM
Profit(Loss)* $1,079.00MM $1,358.00MM $1,378.00MM
Stockholders Equity $5,765.00MM $6,112.00MM $6,067.00MM
Inventory $151.00MM $0.00MM $0.00MM
Assets $25,337.00MM $26,681.00MM $26,899.00MM
Operating Cash Flow $2,260.00MM $2,149.00MM $2,716.00MM
Capital expenditure $674.00MM $649.00MM $0.00MM
Investing Cash Flow $-2,006.00MM $-1,603.00MM $-1,444.00MM
Financing Cash Flow $-329.00MM $-382.00MM $-878.00MM
Earnings Per Share** $5.75 $7.39 $7.60

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.